Search In this Thesis
   Search In this Thesis  
العنوان
Assessment of Interleukin 17 f level in patients with hepatitis C virus infection with or without hepatocellular carcinoma /
المؤلف
Abo Elhassan, Usama Rabee.
هيئة الاعداد
باحث / أسامة ربيع أبوالحسن
مشرف / رانيا السيد شعير
مشرف / محمد رجب أحمد
مشرف / رحاب محمد عبد الكريم
الموضوع
Interleukin-17. Carcinoma, Hepatocellular. Liver Cancer.
تاريخ النشر
2019.
عدد الصفحات
138 P. :
اللغة
الإنجليزية
الدرجة
ماجستير
التخصص
الطب الباطني
الناشر
تاريخ الإجازة
23/3/2019
مكان الإجازة
جامعة بني سويف - كلية الطب - الامراض الباطنية
الفهرس
Only 14 pages are availabe for public view

from 140

from 140

Abstract

Chronic hepatitis C is one of the most serious and serious diseases facing Egyptians in the current era because of the complications that affect human life, including the occurrence of liver fibrosis and cancer, which leads to hepatic failure so it is necessary to detect early chronic hepatitis C to prevent The occurrence of complications and also prevent the occurrence of cancer of the liver where tumors are the cancers of the liver of the most common types of tumors spread among the Egyptians and is one of the most important causes of death in Egypt has been a remarkable development in the last color in the treatment of chronic hepatitis C through a new alternative medicine for interferon due to side effects of hepatitis C on liver function are measured by liver, INR, albumin, jaundice, and fibrosis levels. Numerous studies have been conducted on how cancers of the liver can occur. In this study, a relationship was found between the level of hepatocellular carcinoma Interleukin 17F and its role in the occurrence of chronic hepatitis C and its role in the tumors of the liver cancer was conducted this study on 75 cases, of which 50 cases of chronic hepatitis C of which 25 cases of liver disease and cancer has been withdrawn samples in the hospital Beni Suef The interleukin 17F plays an important role in a number of diseases including rheumatoid arthritis, lupus erythematosus, scleroderma, chronic hepatitis C and other diseases as it is excreted from immune cells and leads to immunosuppressive diseases. In this study, the level of interleukin 17F was measured in patients with hepatitis chronic C-associated and non-hepatocellular carcinoma has been concluded that the level of interleukin 17 F is higher in patients with chronic hepatitis C compared to people who do not suffer from chronic hepatitis C. This indicates the role of interleukin 17F in the occurrence of chronic hepatic C and the occurrence of cancers of the cervical Which gives us hope in the future to discover new medicines to treat chronic hepatitis C and prevent the occurrence of cancerous cancers.